Is Gilead Sciences, Inc. (GILD) Stock at the Top of the Drug Manufacturers

Gilead Sciences, Inc. (GILD) is near the top in its industry group according to InvestorsObserver. GILD gets an overall rating of 76. That means it scores higher than 76 percent of stocks. Gilead Sciences, Inc. gets a 86 rank in the Drug Manufacturers - General industry. Drug Manufacturers - General is number 13 out of 148 industries.

GILD has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on GILD!

See Full GILD Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Gilead Sciences, Inc. Stock Today?

Gilead Sciences, Inc. (GILD) stock is lower by -0.79% while the S&P 500 is higher by 0.76% as of 3:05 PM on Thursday, Jan 26. GILD is lower by -$0.66 from the previous closing price of $84.07 on volume of 2,086,918 shares. Over the past year the S&P 500 is lower by -6.97% while GILD is higher by 23.86%. GILD earned $2.64 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 31.52. Click Here to get the full Stock Report for Gilead Sciences, Inc. stock.